
CJC-1295 NO DAC 10 mg
€8.50 per mg
1 Products
Standard
€84,99
/each
3 Products
5% OFF
€80,74
/each
6 Products
10% OFF
€76,49
/each
8 Products
15% OFF
€72,24
/each
Secure payment via
CJC-1295 NO DAC 10 mg (also known as Modified GRF 1-29) research-grade lyophilized peptide powder in a glass vial. A growth hormone-releasing hormone (GHRH) analog studied in preclinical models for growth hormone secretion, pulsatile GH release and metabolic research.
Research Use Only: All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.
Technical Specifications
Frequently asked questions
Research Overview
CJC-1295 without DAC (Drug Affinity Complex), also referred to as Modified GRF(1-29), is a synthetic analog of growth hormone-releasing hormone. It is studied in experimental models for its ability to stimulate pulsatile growth hormone release while preserving physiological GH secretion patterns.
Primary Research Areas
- Growth hormone secretion: models studying GHRH receptor activation, pulsatile GH release and somatotroph signaling.
- Metabolic research: studies on body composition, fat metabolism, protein synthesis and energy balance.
- IGF-1 axis: experimental systems exploring IGF-1 production, hepatic signaling and growth factor cascades.
- Anti-aging & regeneration: preclinical models investigating tissue repair, recovery and age-related GH decline.
More research on CJC-1295 (no DAC)
Explore preclinical studies, mechanisms of action and references for CJC-1295 (no DAC).
View researchFor Research Use Only
This product is intended solely for in-vitro research and laboratory use. Not intended for human consumption, diagnostic or therapeutic purposes.
Safety & Handling
Handle with appropriate protective equipment (gloves, lab coat, eye protection). Store according to product specifications. Consult the Safety Data Sheet (SDS) for full safety instructions.